DSSSB 12 August 2024
Pharmacology
Easy

What is the drug of choice for Methicillin Staphylococcus aureus (MRSA)?

Appeared in: DSSSB 12 August 2024

Explanation

  • Vancomycin is a glycopeptide antibiotic and is the established drug of choice for treating serious or invasive infections caused by MRSA.
  • MRSA is resistant to all beta-lactam antibiotics (like penicillins and cephalosporins) because it possesses the mecA gene, which produces an altered penicillin-binding protein (PBP2a).
  • Vancomycin bypasses this resistance mechanism by inhibiting bacterial cell wall synthesis at a different target site, making it effective where beta-lactams fail.

Why Other Options Were Wrong

  • Option A: Augmentin is a combination of amoxicillin (a penicillin) and clavulanic acid (a beta-lactamase inhibitor). MRSA's resistance is not due to beta-lactamase enzymes but an altered target site (PBP2a), making Augmentin ineffective.
  • Option C: Azithromycin is a macrolide antibiotic. It is not a first-line treatment for MRSA due to high rates of resistance and because it is generally bacteriostatic, whereas a bactericidal agent is preferred for serious infections.
  • Option D: Amoxicillin is a penicillin-class antibiotic. The 'M' in MRSA stands for Methicillin-resistant, which confers resistance to virtually all penicillin and cephalosporin antibiotics, including amoxicillin.

Related Visual

Visual explanation — Related Visual
Clinical Relevance
  • Nursing practice connection: Knowing Pharmacological management of Methicillin-Resistant Staphylococcus aureus (MRSA) helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
  • Recognizing that Vancomycin is the drug of choice for MRSA is critical for patient safety, as using an ineffective antibiotic like a penicillin can lead to treatment failure, sepsis, and death.
  • Nurses must administer Vancomycin via slow IV infusion (over at least 60-90 minutes) to prevent Red Man Syndrome, a common and distressing infusion-related reaction.
  • Therapeutic drug monitoring of vancomycin trough levels is a key nursing responsibility to ensure efficacy while preventing dose-related toxicities like kidney damage (nephrotoxicity) and hearing loss (ototoxicity).
How to Approach the Question
  • First, identify the key pathogen in the question: 'Methicillin-Resistant Staphylococcus aureus (MRSA)'.
  • Recall the meaning of 'Methicillin-Resistant'. This signifies that the bacterium is resistant to all beta-lactam antibiotics, which includes the entire penicillin and cephalosporin families.
  • Examine the options and eliminate any beta-lactam antibiotics. 'Augmentin' (amoxicillin/clavulanate) and 'Amoxycillin' are both penicillin-based drugs and are therefore ineffective.
  • Consider the remaining options. 'Azithromycin' is a macrolide, which has high rates of MRSA resistance and is not a primary choice.
  • This leaves 'Vancomycin', a glycopeptide antibiotic, which is the well-established gold standard for treating serious MRSA infections. Select this as the correct answer.
Concept Tested & Keywords
  • Concept Tested: Pharmacological management of Methicillin-Resistant Staphylococcus aureus (MRSA).
  • Stem keywords: Methicillin Staphylococcus aureus, MRSA, drug of choice
  • Lead-in keywords: What is
  • Negative lead-in flag: false

Question ID

QdjojCQf0WUTqNCzoA6i0S

Reference Book

E6 Microbiology Essentials Sastry 4e Part 2 p. 70-72

E6 Medicine Harrison 22e Part 1 p. 1245-1247

Practise the full DSSSB 12 August 2024

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Antimicrobial Drugs Questions

More DSSSB 12 August 2024 Questions